PRESS RELEASE
August 26, 2014
The Election of James B. McCarthy MBA JD and
Thais Russomano MD PhD
to the ISMC Board of Directors
I am pleased to announce the nomination and election of James McCarthy and Thais Russomano to the International Space Medicine Consortium Board of Directors.
James (Jim) B. McCarthy MBA JD
Jim brings to the Board an outstanding record of success and business development in the global healthcare and medical markets. Jim is the Chairman and CEO of Gemini Consulting Group, Inc., Oak Brook, Illinois, a healthcare consulting firm that addresses legal, organizational structure and financial strategic advisory services for clients and partners. His experience includes:
developing and managing hospitals, ambulatory surgery centers, and diagnostic centers in both the U.S. and overseas;
developing and implementing hospital and physician joint venture arrangements in the U.S. and overseas; and
implementing domestic and international medical supply and equipment arrangements.Jim has held positions as Vice President and General Manager of a medical device manufacturing company in Chicago, and spent five years in increasingly responsible planning positions with the Medical Products Division of 3M Company.
Of special interest to ISMC is Jim’s co-founding of Magellan Global Health, Inc., Panama City, Panama, where he also serves on the Board of Directors of its U.S. subsidiary, CareSpan USA, Inc. CareSpan, a multinational healthcare delivery company, provides cloud-based direct medical care which is facilitated by the global reach of interactive telemedicine whereby doctors and nurses provide primary care, wellness and disease prevention to remote workers and other populations with inadequate medical infrastructure.
Jim received his BA from the University of Notre Dame, his JD from the Loyola University School of Law, and his MBA from the Keller Graduate School of Management. He is a member of various state and national organizations, including the American Health Lawyers Association. He also serves on the National Advisory Council of the Keller Graduate School of Management, Chicago, Illinois and is a member of the British-American Business Council, Chicago, Illinois and the National Strategy Forum, Chicago, Illinois.
Jim also serves on the Board of Directors of E-P Therapeutics, Inc., Ridgefield, Connecticut and is a member of the Board of Trustees of the University of San Diego, San Diego, California where he is Chairman of the Student Affairs Committee and serves on the Executive Committee, Audit Committee and Committee on Trustees.
Jim and I have served as Directors together on public and private corporations operating in the fields of Stem Cell Therapeutics, Strategic Defense Initiative (Star Wars Program), environmental services and the semiconductor industry. He has also served on the Board of Directors of Wintrust Financial Corporation (WTFC) Rosemont, Illinois, Hinsdale Bank and Trust Company, Hinsdale, Illinois, Protein Polymer Technologies, Inc. (PPTI) San Diego, California, JMAR Technologies, Inc. (JMAR) San Diego, California, StemCyte, Inc., Covina, California and Sirigen Group Ltd., London, England.
THAIS RUSSOMANO MD PhD
Thais is the Chief Medical Officer (CMO) of the International Space Medicine Consortium (ISMC) in a role providing leadership, direction and planning for a wide variety of projects and researches related to mankind in the space environment.
Thais cultivates, facilitates and coordinates professional relationships and collaborations with partner researchers and institutions in line with ISMC mission to develop new technologies and processes leading to the support and sustainability of human life in extreme terrestrial and extraterrestrial environments.
She has more than twenty years of experience in the field of Space Life Sciences with a strong academic and research background. She single-handedly founded the Microgravity Center in Brazil, a unique and internationally recognized reference center in Latin America in the study of Human Space Physiology and Space Biomedical Engineering, now boasting nine laboratories focused in the fields of Aerospace Medicine, Human Physiology, Biomedical Engineering, and Telemedicine & eHealth.
A medical doctor specializing in internal and emergency medicine, Thais completed her Master’s Degree in Aerospace Medicine at Wright State University, Ohio, USA in 1991 and subsequently, a PhD in Space Physiology at King’s College London, UK in 1998.
Thais is an active participant in the international scientific community, being an elected Academician of the International Academy of Astronautics (IAA), and the International Academy of Aviation and, among others. She continues to contribute to international working groups in the field of manned space flight, most recently as a part of the International Space Committee’s ISO Space Systems – Man-Life Activity Support Systems and Equipment Integration in Space Flight, and the IAA, Medical Safety Guidelines for Space Crews Involved in Short-Duration Commercial Orbital Flight Operations.
Thais is the holder of seven patents for products and processes related to Space Life Sciences and Aerospace Biomedical Engineering.
Currently, one of Thais’s patented biomedical devices, Earlobe Arterial Blood Collector, is part of the London Museum of Science Exhibition
We at the ISMC are very enthused to have Jim and Thais join our Board of Directors to support our founding vision to advance the state-of-the-art in the innovative field of space medicine and to collaborate with leading space communities and organizations in the exciting area of human space exploration.
Please join in congratulating and welcoming Jim and Thais to the ISMC Board of Directors
Sincerely,
Barry Ressler
Chairman, Board of Directors
International Space Medicine Consortium, ISMC
ISMC
“Connecting Space and Humanity”
A NEW VISION… A NEW PARADIGM
Contact: info@spacemedicineconsortium.org